NASDAQ · Biotechnology
Agenus Inc (AGEN)
$5.97
-2.77%
44
In band
Moving averages
SMA 200$5.05+18.22%
Company profile
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$326.68M
P/E ratio30.08
EPS$0.24
Beta1.523
Dividend yield0.00%
52-week high$10.31
52-week low$2.71
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
OCGN
Ocugen Inc
RSI 39
EDIT
Editas Medicine Inc
RSI 30
DTIL
Precision Biosciences Inc
RSI 45
ALLO
Allogene Therapeutics Inc
RSI 19
ALT
Altimmune Inc
RSI 23
ARCT
Arcturus Therapeutics Holdings Inc
RSI 36
RSI alerts for AGEN
An email when AGEN closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 4:17 AM EST